Current drugs for pancreatic cancer lose effectiveness within months because the tumor becomes resistant. Now, a group from Spain's National Cancer Research Centre (CNIO) has been able to avoid the ...

A new four-marker blood test accurately detects pancreatic cancer, including early stages, raising hopes for earlier diagnosis and improved survival pending further studies. Scientists backed by the ( ...

Dr. Shaheen discusses a complex pancreatic neuroendocrine tumor case, emphasizing tailored treatment goals that balance tumor control and quality of life.

Doctors share what the findings may mean for the future of cancer treatment.

What if creeping fat in Crohn’s disease isn’t collateral damage, but rather the body’s attempt to trap microbiota escaping the intestine, only to become a driver of fibrosis and disease progression ...

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the ...